Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - KEMPHARM, INC | kmph20171231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex_104680.htm |
| EX-32.1 - EXHIBIT 32.1 - KEMPHARM, INC | ex_104679.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex_104678.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex_104676.htm |
| EX-23.1 - EXHIBIT 23.1 - KEMPHARM, INC | ex_104675.htm |
| EX-10.27 - EXHIBIT 10.27 - KEMPHARM, INC | ex_106556.htm |
| EX-10.14 - EXHIBIT 10.14 - KEMPHARM, INC | ex_108319.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-216858) pertaining to the 2014 Equity Incentive Plan of KemPharm, Inc., |
| (2) | Registration Statement (Form S-3 No. 333-213926) of KemPharm, Inc., |
|
(3) |
Registration Statement (Form S-8 No. 333-210369) pertaining to the 2014 Equity Incentive Plan of KemPharm, Inc., and |
|
(4) |
Registration Statement (Form S-8 No. 333-203703) pertaining to the Incentive Stock Plan, as amended, and the 2014 Equity Incentive Plan of KemPharm, Inc. |
of our report dated March 10, 2017 (except for the effects of the retrospective adoption of Accounting Standards Update 2016-18 discussed in Note A, Reclassifications, as to which the date is March 30, 2018), with respect to the financial statements of KemPharm, Inc. included in this Annual Report (Form 10-K) of KemPharm, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Certified Public Accountants
Tampa, Florida
March 30, 2018